乳酸脱酶缺乏的癌细胞对Ym155诱导的DNA损伤的敏感性增加了
Qianjin Guo1, Sooyeon Lee1, Neali Armstrong1
1Department of Medicine, Division of Endocrinology, Stanford University, Stanford, CA, USA.
Endocrine-related cancer
|February 19, 2026
概括
与SDHB缺乏症相关的遗传性色细胞瘤和偏角细胞瘤 (hPPGL) 综合征显示出转移风险增加. 研究人员发现,Ym155化疗通过诱导DNA损伤和ROS生成,优先针对SDHB缺乏癌症.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 生物化学 生物化学
背景情况:
- 遗传性叶色红细胞瘤和偏角细胞瘤 (hPPGL) 综合征是由酸脱酶 (SDHx) 基因中的生殖线突变引起的.
- 缺少SDHB的瘤表现出更高的转移潜力,目前的治疗只提供息护理,突显出迫切需要新型疗法.
研究的目的:
- 为了确定新的线粒体导向细胞毒剂,选择性向SDHB缺乏癌症.
- 探索Ym155在SDHB缺乏恶性瘤中的治疗潜力.
主要方法:
- 使用了人类SDHB缺乏的UOK269 RCC细胞 (SDHB-KO) 和同源的SDHB重建的对照细胞 (SDHB-WT).
- 测试了线粒体离子体和化疗化合物Ym155的选择性细胞毒性.
- 验证了人类原发性乳色素瘤细胞,小鼠乳色素瘤细胞系和初级SDHB缺乏的小鼠细胞的发现.
- 研究了基因组脱甲酶KDM4和DNA修复途径的作用.
主要成果:
- 线粒体离子体对SDHB-KO细胞表现出偏好的细胞毒性.
- Ym155对缺乏SDHB的细胞,包括原发性瘤细胞,表现出强烈和选择性的细胞毒性.
- 缺少SDHB使细胞对Ym155诱导的DNA损伤和反应性氧物种 (ROS) 产生敏感.
- 抑制KDM4,是SDH缺乏的下游效应,模仿Ym155的敏感性.
结论:
- 缺乏SDHB的癌症表现出内在的脆弱性,可以在治疗上加以利用.
- Ym155代表了对SDHB缺乏瘤的有前途的治疗剂,因为它能够诱导DNA损伤和ROS.
- 在SDH缺乏的瘤中酸盐的积累会损害KDM4活性和DNA修复,增加对Ym155.5的敏感性.
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Mutations
44.8K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.8K
Electron Transport Chain: Complex I and II
19.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
DNA Damage can Stall the Cell Cycle
10.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle
3.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K


